We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Foghorn Therapeutics Inc | NASDAQ:FHTX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.61 | 4.02 | 8.96 | 0 | 09:16:37 |
Wells Fargo 2023 Healthcare Conference
Morgan Stanley 21st Annual Global Healthcare Conference
H.C. Wainwright 25th Annual Global Investment Conference
A webcast of the fireside chat can also be accessed under “Events & Presentations” in the Investors section of Foghorn’s website, www.foghorntx.com, and will be available for 30 days.
About Foghorn Therapeutics
Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control® platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The Company is developing multiple product candidates in oncology. Visit our website at www.foghorntx.com for more information about the company, and follow us on X (formerly Twitter) and LinkedIn.
Contact:
Ben Strain, Foghorn Therapeutics Inc. (Media and Investors)bstrain@foghorntx.com
Karin Hellsvik, Foghorn Therapeutics Inc. (Media)khellsvik@foghorntx.com
1 Year Foghorn Therapeutics Chart |
1 Month Foghorn Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions